Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Synthetic Phosphoethanolamine in Solid Tumors
NCT02950103Phase 2Terminated
- Sponsor
- Secretaria de Estado da Saúde
- Start
- Aug 2016
- Primary completion
- Mar 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of phosphorylcolamine in solid tumor, sponsored by Secretaria de Estado da Saúde. Started Aug 2016; status: terminated.
02
Drugs
phosphorylcolamine
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT02950103.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02950103.